Eosinophilic Gastrointestinal Disease Program | Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Contact the Eosinophilic Esophagitis Program

The 325,000 square-foot Karp Family Research Building opened its doors October 2003.While we are learning more about the cause and treatment of EGIDs, a lot remains uncertain. The EGID Program at Boston Children’s Hospital is actively involved in cutting edge research with basic science, clinical and translational studies.

You may be offered the opportunity to participate in a study. Please know that while conducting research is a very important mission of our program, your child’s care in the EGID Program will never be compromised should you decline to participate.

The EGID Program is currently conducting the following clinical trials. Click each link to learn more:

  • Esophagitis Registry

  • A Prospective Case-Controlled Study to Identify Novel Biologic Markers Associated with Eosinophilic Esophagitis

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337